ATE471316T1 - Diastereoselektives syntheseverfahren mit 6-brom- 4-(3-chlorphenyl)-2-methoxychinolin - Google Patents

Diastereoselektives syntheseverfahren mit 6-brom- 4-(3-chlorphenyl)-2-methoxychinolin

Info

Publication number
ATE471316T1
ATE471316T1 AT05736074T AT05736074T ATE471316T1 AT E471316 T1 ATE471316 T1 AT E471316T1 AT 05736074 T AT05736074 T AT 05736074T AT 05736074 T AT05736074 T AT 05736074T AT E471316 T1 ATE471316 T1 AT E471316T1
Authority
AT
Austria
Prior art keywords
methoxyquinoline
chlorphenyl
bromine
synthesis method
diastereoselective synthesis
Prior art date
Application number
AT05736074T
Other languages
English (en)
Inventor
Walter Filliers
Rudy Broeckx
Patrick Angibaud
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE471316T1 publication Critical patent/ATE471316T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT05736074T 2004-05-03 2005-04-28 Diastereoselektives syntheseverfahren mit 6-brom- 4-(3-chlorphenyl)-2-methoxychinolin ATE471316T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04076321 2004-05-03
PCT/EP2005/051932 WO2005105783A1 (en) 2004-05-03 2005-04-28 Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2-methoxy-quinoline

Publications (1)

Publication Number Publication Date
ATE471316T1 true ATE471316T1 (de) 2010-07-15

Family

ID=34965002

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05736074T ATE471316T1 (de) 2004-05-03 2005-04-28 Diastereoselektives syntheseverfahren mit 6-brom- 4-(3-chlorphenyl)-2-methoxychinolin

Country Status (10)

Country Link
US (1) US7572916B2 (de)
EP (1) EP1756085B1 (de)
JP (1) JP4917022B2 (de)
CN (1) CN100567291C (de)
AT (1) ATE471316T1 (de)
AU (1) AU2005238222B2 (de)
CA (1) CA2563806C (de)
DE (1) DE602005021878D1 (de)
ES (1) ES2346986T3 (de)
WO (1) WO2005105783A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009313927A1 (en) 2008-11-13 2010-05-20 Astrazeneca Ab Azaquinolinone derivatives and uses thereof
US10471055B2 (en) 2015-08-17 2019-11-12 Kura Oncology, Inc. Methods of treating cancer patients with farnesyltransferase inhibitors
HRP20210544T1 (hr) 2016-11-03 2021-08-20 Kura Oncology, Inc. Inhibitori farneziltransferaze za uporabu u liječenju raka
WO2019222565A1 (en) 2018-05-18 2019-11-21 Kura Oncology, Inc. Synthesis of tipifarnib

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69635966T2 (de) * 1995-12-08 2006-11-30 Janssen Pharmaceutica N.V. (Imidazol-5-yl)Methyl-2-Chinolinonderivate als Farnesyl Protein transferase Inhibitoren
WO2001051126A1 (en) * 2000-01-12 2001-07-19 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
AU2001227756A1 (en) 2000-01-12 2001-07-24 Merck And Co., Inc. Inhibitors of prenyl-protein transferase
HN2000000266A (es) * 2000-01-21 2001-05-21 Pfizer Prod Inc Compuesto anticanceroso y metodo de separacion de enantiomeros util para sintetizar dicho compuesto.
AU2001290588A1 (en) 2000-09-05 2002-03-22 Merck And Co., Inc. Inhibitors of prenyl-protein transferase
ES2236505T3 (es) * 2001-03-12 2005-07-16 Janssen Pharmaceutica N.V. Procedimiento para la preparacin de compuestos de imidazol.
WO2002079147A2 (en) 2001-03-30 2002-10-10 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
WO2004037816A1 (en) * 2002-10-28 2004-05-06 Chugai Seiyaku Kabushiki Kaisha Benzofuran compounds having antitumor activity
WO2004076446A1 (ja) * 2003-02-27 2004-09-10 Chugai Seiyaku Kabushiki Kaisha ベンゾチオフェン誘導体
JP4917021B2 (ja) * 2004-05-03 2012-04-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ スルフィンイミン類に対するリチオ化されたｎ−メチルイミダゾールのジアステレオ選択的付加

Also Published As

Publication number Publication date
AU2005238222B2 (en) 2010-10-28
CN1946710A (zh) 2007-04-11
US7572916B2 (en) 2009-08-11
JP2007536334A (ja) 2007-12-13
EP1756085A1 (de) 2007-02-28
CN100567291C (zh) 2009-12-09
JP4917022B2 (ja) 2012-04-18
US20070293680A1 (en) 2007-12-20
ES2346986T3 (es) 2010-10-22
CA2563806A1 (en) 2005-11-10
WO2005105783A1 (en) 2005-11-10
HK1101398A1 (en) 2007-10-18
CA2563806C (en) 2012-11-20
DE602005021878D1 (de) 2010-07-29
EP1756085B1 (de) 2010-06-16
AU2005238222A1 (en) 2005-11-10

Similar Documents

Publication Publication Date Title
IL217962A0 (en) Process for the preparation of a 2-pyridylethylcarboxamide derivative
SG166019A1 (en) Quinoline derivatives and use thereof as mycobacterial inhibitors
EA200800728A1 (ru) Полиморфы бензоатной соли 2-[[6-[(3r)-3-амино-1-пиперидинил]-3,4-дигидро-3-метил-2,4-диоксо-1(2н)-пиримидинил]метил]бензонитрила и способы их применения
TW200800947A (en) Trisubstituted amine compound
NO20080761L (no) Acykliske Ikur inhibitorer
EA200800727A1 (ru) Введение ингибиторов дипептидилпептидазы
WO2007026920A3 (en) Amide derivatives as rock inhibitors
NZ591449A (en) Picolinamide derivatives as kinase inhibitors
IL183663A0 (en) Process for the preparation of a 2-ethylaminopyridine derivative
NO20070368L (no) Virale polymeraseinhibitorer
DE60316013D1 (de) Heteroaryl-pyrimidinderivate als jak-inhibitoren
EA200900779A1 (ru) Производные дигидропиридина, полезные как ингибиторы протеинкиназы
NO20071050L (no) Rapamycin-polymorf II og anvendelser derav
MX2012002752A (es) Compuestos de heteroarilo como inhibidores de cinasa.
EP1951686A4 (de) Chinazolinderivate als multiplex-inhibitor und verfahren zu deren herstellung
WO2009121033A3 (en) Substituted nitrogen heterocycles and synthesis and uses thereof
TW200640913A (en) 5-Substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents
MX2009004290A (es) Inhibidores de proteasas de catepsina.
MX2007009282A (es) Nuevos procesos para la preparacion de un 2h-cromeno.
EA200601363A1 (ru) Замещённые хинолины и их применение в качестве микобактериальных ингибиторов
ZA200704913B (en) 3-[2-(3-acylamino-2-oxo-2H-pyridin-1-YL)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors
DE602005021878D1 (de) Diastereoselektives syntheseverfahren mit 6-brom-4-(3-chlorphenyl)-2-methoxychinolin
ATE445396T1 (de) 3-arylthioindol-2-carbonsäureamidderivate und ihre analoge als hemmer von caseinkinase i
EA200601678A1 (ru) Новые имидазолы
DE602005007604D1 (de) Diastereoselektive addition von lithiiertem n-methylimidazol an sulfinimine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties